Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Deferred Revenue (2020 - 2024)

Historic Current Deferred Revenue for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $239.7 million.

  • Cellebrite DI's Current Deferred Revenue rose 1596.41% to $239.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.7 million, marking a year-over-year increase of 1596.41%. This contributed to the annual value of $217.0 million for FY2024, which is 1064.68% down from last year.
  • Cellebrite DI's Current Deferred Revenue amounted to $239.7 million in Q3 2025, which was up 1596.41% from $227.2 million recorded in Q2 2025.
  • Cellebrite DI's Current Deferred Revenue's 5-year high stood at $242.8 million during Q4 2023, with a 5-year trough of $115.0 million in Q3 2021.
  • For the 5-year period, Cellebrite DI's Current Deferred Revenue averaged around $179.7 million, with its median value being $183.9 million (2024).
  • As far as peak fluctuations go, Cellebrite DI's Current Deferred Revenue skyrocketed by 3406.04% in 2023, and later crashed by 1064.68% in 2024.
  • Cellebrite DI's Current Deferred Revenue (Quarter) stood at $159.4 million in 2021, then grew by 22.25% to $194.9 million in 2022, then rose by 24.6% to $242.8 million in 2023, then dropped by 10.65% to $217.0 million in 2024, then grew by 10.47% to $239.7 million in 2025.
  • Its Current Deferred Revenue stands at $239.7 million for Q3 2025, versus $227.2 million for Q2 2025 and $219.4 million for Q1 2025.